4-Title: Pharmacokinetics of cefquinome in Marathwadi buffalo calves

Authors: MK Patil, AP Somkuwar and PV Patil

Source: Ruminant Science (2020)-9(2):229-232.

How to cite this manuscript: Patil MK, Somkuwar AP and Patil PV (2020). Pharmacokinetics of cefquinome in Marathwadi buffalo calves. Ruminant Science 9(2):229-232.


The present experiment was performed on six healthy Marathwadi buffalo calves of either sex to study the different pharmacokinetic parameters after a single intramuscular administration of cefquinome @ 2 mg/kg body weight by microbiological assay technique. The values of Absorption half life, distribution half life, elimination half life, volume of distribution, total body clearance, AUC, AUMC, MRT and bioavailability found were 0.24±0.02 h, 0.30±0.03 h, 2.54±0.12 h, 1.85±0.17 L/kg (Vd(B)) and 1.95±0.19 L/kg (Vdss), 0.52±0.04 L/kg.h-1, 3.99 ±0.35 µg/ml.hr, 14.93±1.48 µg/ml.hr2, 3.75± 0.18 h and 165.38%, respectively. It may be concluded that the elimination half life of cefquinome was 2.54 h in buffalo calves indicating the repeating of doses at 12 to 15 h intervals in buffalo calves.


Baggot JD (1977). Principle of drug disposition in domestic animals. In: The Basis of Veterinary Clinical Pharmacology. 1st Edn, WB Saunders Co, Philadelphia p 238.

Bennet JV, Brodie JL, Benner EJ and Kirby MM (1966). Simplified accurate method for antibiotic assay in clinical specimen. Applied Microbiology 14:170-177.

Black WD, Holt JD and Gentry RD (1983). Pharmacokinetic study of neomycin in calves following intravenous and intramuscular administration. Canadian Journal of Comparative Medicine 47:433-435.

Errecalde CA, Guillermo FP, Pulles Ignacio, Luders CF and Ovando HG (2002). Farmacocinetica de cefquinomeen terneros por aplicacion intramuscular. Revista Colombiana de Ciencias Pecuarias 15(3):281-285.

Gibaldi M and Perrier D (1982). Pharmacokinetics. 2nd Edn, Marcel Dedder, NewYork. p 494.

Li XB, Wu WX, Su D, Wang ZJ, Jiang HY and Shen JZ (2008). Pharmacokinetics and bioavailability of cefquinome in healthy piglets. Journal of Veterinary Pharmacology and Therapeutics 31:523-527.

Limbert M, Dieter I, Norbert K, Astrid M, Karl S, Gerhard S and Elmar S (1991). Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V): A new broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy 35(1):14-19.

Maha ZG (2005). Pharmacokinetics of cefquinome and tissue concentration in broilers. Bulletin of Faculty of Pharmacy-Cairo University 43(2):201-207.

Murphy SP, Erwin ME and Jones RN (1994). Cefquinome (HR 111V) in vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals. Diagnostic Microbiology and Infectious Disease 20:49-55.

Riviere JE, Papich MG and Richard AH (2011). Veterinary Pharmacology and Therapeutics. 9th Edition. Wiley Blackwell, United States. p 1552.

Shpigel NY, Levin D, Winkler M, Saran A, Ziv G and Bottner A (1997). Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. Journal Dairy Science 80:318-323.

Snedecor GW and Cochran WG (1994). Statistical Methods. 8th Edn, Oxford and IBH Publications, New Delhi.

Suhren G and Knappstein K (2003). Detection of cefquinome in milk by liquid chromatography and screening methods. Analytica Chimica Acta. pp 363-372.

Tohamy MA, Smail MI and EI-Gendy AM (2006).Comparative pharmacokinetics of cefquinome in ruminants. Journal of Egyptian Society of Pharmacology and Experimental Therapeutics 4:12-18.

Venkatachalam D, Dumka, VK and Ranjan B (2018). Pharmacokinetics of a single intramuscular injection of cefquinome in buffalo calves. Journal of Veterinary Pharmacology and Therapeutics 41:155-8.

Yang Dawei, Chen Zhang, Liu Ding, Huan Zhong, Shen XiangGuang, Xu Susi and Gu XiaoYan (2009). Pharmacokinetics and bioavailability of cefquinome in pigs. Chinese Journal of Veterinary Science 29(9):1182-1185.